results

ETC Announces Fiscal 2026 Second Quarter Results

SOUTHAMPTON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Environmental Tectonics Corporation (OTCID: ETCC) (“ETC” or the “Company”) today reported its…

5 months ago

DB-OTO Results in theNew England Journal of Medicine Showcase Dramatic and Sustained Improvements in Hearing and Speech Perception in Children with Profound Genetic Hearing Loss

Nearly all participants (11 of 12) experienced clinically meaningful hearing improvements, including three who achieved normal hearing; eight with longer…

5 months ago

LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025

BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third…

6 months ago

InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow

The Company reports NIS 130 million in revenue and NIS 12 million in positive operating cash flow, demonstrating resilience and…

6 months ago

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data 50 mg once-daily dose of obefazimod led…

6 months ago

Kia Announces September 2025 Global Sales Results

September 2025 global sales of 268,238 units, up 7.3% Y/ySales in Korea climbed to 49,001 units, up 28.5% Y/yOutside of…

6 months ago

YD Bio Limited Reports Unaudited Half Year 2025 Financial Results

September 30, 2025 17:25 ET  | Source: YD Bio Limited TAIWAN, Sept. 30, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited…

6 months ago

Euro NCAP to Launch New SAFER TRUCKS Results

WhatLatest Euro NCAP truck safety results published online and via social media.WhenTuesday 30 September - 11:00 a.m. CEST.WhereGo to Euro NCAP's Press…

6 months ago

NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Nave or Resistant R/M-HNSCC

Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïve or resistant to anti-PD-163% (26/41)…

6 months ago

Silynxcom Announces First Half of 2025 Financial Results, Expands Client Diversity and Raised $2.9M to Support Growth

September 26, 2025 16:05 ET  | Source: Silynxcom Ltd. Netanya, Israel, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE…

6 months ago